Ritonavirs steady- state farmakokinetiske parametre blev undersøgt hos HIV- inficerede børn under 2 år, som fik doser fra 350 til 450 mg/ m² to gange daglig.
Ritonavir steady-state pharmacokinetic parameters were evaluated in HIV infected children less than 2 years of age receiving doses ranging from 350 to 450 mg/m² twice daily.